8 studies found for:    10-N-0121
Show Display Options
Rank Status Study
1 Active, not recruiting Oxidative Stress in Motor Neuron Disease: COSMOS Add-On Study
Conditions: Motor Neuron Disease;   Primary Lateral Sclerosis
Intervention:
2 Completed Combination Chemotherapy in Treating Children With Refractory or Relapsed Hodgkin's Lymphoma
Condition: Lymphoma
Interventions: Biological: filgrastim;   Drug: ifosfamide;   Drug: vinorelbine tartrate
3 Completed S0121, Neoadjuvant Carboplatin, Paclitaxel, and Gemcitabine Followed by Cisplatin and Radiation Therapy in Treating Patients With Locally Advanced or Recurrent Carcinoma of the Urothelium
Conditions: Bladder Cancer;   Urethral Cancer
Interventions: Drug: carboplatin;   Drug: cisplatin;   Drug: gemcitabine hydrochloride;   Drug: paclitaxel;   Procedure: neoadjuvant therapy;   Radiation: radiation therapy
4 Recruiting Evaluation of Oral Activated Charcoal on the Ability of an Antimalarial Drug to Kill Parasites in Malian Children With Mild Malaria
Conditions: Malaria;   Severe Malaria
Interventions: Drug: Actidose Aqua;   Drug: Artesunate;   Drug: Amodiaquine
5 Active, not recruiting Phase 3b Open Label Study to Evaluate Switching From Regimens Consisting of a Non-nucleoside Reverse Transcriptase Inhibitor Plus Emtricitabine and Tenofovir DF to the Elvitegravir/Cobicistat/Emtricitabine/Tenofovir DF Single-Tablet Regimen in Virologically Suppressed, HIV 1 Infected Patients
Conditions: Acquired Immunodeficiency Syndrome;   HIV Infections
Interventions: Drug: Stribild;   Drug: TVD;   Drug: NNRTI
6 Completed Chemotherapy in Treating Children With Down Syndrome and Myeloproliferative Disorder, Acute Myelogenous Leukemia, or Myelodysplastic Syndrome
Conditions: Leukemia;   Myelodysplastic Syndromes;   Myelodysplastic/Myeloproliferative Neoplasms
Interventions: Drug: asparaginase;   Drug: cytarabine;   Drug: daunorubicin hydrochloride;   Drug: methotrexate;   Drug: therapeutic hydrocortisone;   Drug: thioguanine
7 Recruiting Phase 4: Investigational Study to Evaluate Metformin XR Monotherapy Versus Metformin IR Monotherapy in Subjects With Type 2 Diabetes
Condition: Type 2 Diabetes Mellitus
Interventions: Drug: Metformin XR;   Drug: Metformin IR;   Drug: Placebo matching with Metformin XR;   Drug: Placebo matching with Metformin IR
8 Unknown  Long Term Tapering or Standard Steroids for Nephrotic Syndrome
Condition: Nephrotic Syndrome
Interventions: Drug: long term tapering of prednisolone;   Drug: standard prednisolone treatment

Indicates status has not been verified in more than two years